Skip to main content
. 2020 Oct 27;11:594152. doi: 10.3389/fneur.2020.594152

Figure 1.

Figure 1

Flowchart of the participants included in the current study. n, number of patients; QMG, quantitative myasthenia gravis score; MG-ADL, myasthenia gravis activities of daily living; IVIG, intravenous immunoglobulin; AEs, adverse events.